A nutritional supplement for post-Covid chronic fatigue

Post-Covid syndrome is a condition that often occurs in subject who have had mild or severe Sars-CoV-2 infection and it is mainly characterized by chronic fatigue. Recently a published study evaluated a nutritional supplement, supporting immune function and energy metabolism (Apportal®, Pharmanutra), on chronic fatigue after Sars-CoV-2 infection.

PharmaNutra R&D laboratory

Image Credit: PharmaNutra

Results of the study showed a significant improvement in quality of life and chronic fatigue both after 14 and 28 days of taking Apportal®. The condition of chronic fatigue observed in these SARS-CoV-2 infected subjects is comparable with those observed in other chronic diseases. Apportal® can be a quick and easy opportunity to counteract chronic fatigue.

Last updated: Oct 28, 2021 at 6:20 AM

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    PharmaNutra Spa. (2021, October 28). A nutritional supplement for post-Covid chronic fatigue. News-Medical. Retrieved on December 08, 2021 from https://www.news-medical.net/whitepaper/20211028/A-nutritional-supplement-for-post-Covid-chronic-fatigue.aspx.

  • MLA

    PharmaNutra Spa. "A nutritional supplement for post-Covid chronic fatigue". News-Medical. 08 December 2021. <https://www.news-medical.net/whitepaper/20211028/A-nutritional-supplement-for-post-Covid-chronic-fatigue.aspx>.

  • Chicago

    PharmaNutra Spa. "A nutritional supplement for post-Covid chronic fatigue". News-Medical. https://www.news-medical.net/whitepaper/20211028/A-nutritional-supplement-for-post-Covid-chronic-fatigue.aspx. (accessed December 08, 2021).

  • Harvard

    PharmaNutra Spa. 2021. A nutritional supplement for post-Covid chronic fatigue. News-Medical, viewed 08 December 2021, https://www.news-medical.net/whitepaper/20211028/A-nutritional-supplement-for-post-Covid-chronic-fatigue.aspx.

Other White Papers by this Supplier